Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thyroid Associated Ophthalmopathy”

213 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 213 results

Not applicableUnknownNCT01579344
What this trial is testing

Lacrimal Drainage System Obstruction Associated to Radioactive Iodine Therapy for Thyroid Carcinoma

Who this might be right for
Lacrimal Apparatus Disease
Fabricio Lopes da Fonseca 100
Not applicableStudy completedNCT03278964
What this trial is testing

Analysis Between the Results of Two Surgical Techniques of Orbital Decompression in Patients With Graves Orbitopathy

Who this might be right for
Graves Ophthalmopathy
University of Sao Paulo General Hospital 42
Post-approval studies (Phase 4)Looking for participantsNCT07265258
What this trial is testing

Teprotumumab N01 in Subjects With Active Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Innovent Biologics (Suzhou) Co. Ltd. 92
Not applicableLooking for participantsNCT05012033
What this trial is testing

Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting

Who this might be right for
Thyroid Eye DiseaseVasculitisCOPD Exacerbation Acute+2 more
Imperial College London 120
Large-scale testing (Phase 3)Looking for participantsNCT03131726
What this trial is testing

Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)

Who this might be right for
Graves OphthalmopathyThyroid Associated OphthalmopathyThyroid Associated Orbitopathy
Lund University 80
Large-scale testing (Phase 3)Ended earlyNCT04737330
What this trial is testing

The Efficacy and Safety of Secukinumab 300 mg in Patients With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye DiseaseGraves Orbitopathy
Novartis Pharmaceuticals 28
Early research (Phase 1)Study completedNCT06674941
What this trial is testing

A Trial to Investigate Teprotumumab (High-concentration Formulation) Subcutaneous Administration in Healthy Adult Non-Japanese and Japanese Participants

Who this might be right for
Healthy Volunteers
Amgen 44
Not applicableStudy completedNCT01798966
What this trial is testing

Twenty-four Hour Intraocular Pressure Patterns in Patients With Uncontrolled Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Sensimed AG 10
Not applicableEnded earlyNCT02316691
What this trial is testing

B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
University of Pittsburgh 2
Large-scale testing (Phase 3)Active Not RecruitingNCT06625398
What this trial is testing

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 204
Post-approval studies (Phase 4)Study completedNCT03948191
What this trial is testing

99Tc-MDP for Thyroid-Associated Ophthalmopathy

Who this might be right for
Thyroid-Associated Ophthalmopathy
Dalian University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06088979
What this trial is testing

Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Tourmaline Bio, Inc., a Novartis Company 79
Large-scale testing (Phase 3)Not Yet RecruitingNCT05049603
What this trial is testing

Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study

Who this might be right for
Graves' Orbitopathy
University of Pisa 102
Large-scale testing (Phase 3)Study completedNCT06269393
What this trial is testing

IBI311 in Subjects With Steroid-resistant, Thyroid Associated Ophthalmopathy

Who this might be right for
Thyroid Associated Ophthalmopathy
Peking University People's Hospital 53
Large-scale testing (Phase 3)Not Yet RecruitingNCT07622121
What this trial is testing

Treatment of Chronic Thyroid Eye Disease With MHB018A

Who this might be right for
Thyroid Eye Disease, TED
Minghui Pharmaceutical (Hangzhou) Ltd 135
Testing effectiveness (Phase 2)Ended earlyNCT03938545
What this trial is testing

ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO )

Who this might be right for
Graves' Ophthalmopathy (GO)
Immunovant Sciences GmbH 65
Not applicableLooking for participantsNCT07381413
What this trial is testing

Eye Tracking Study on Eye Movement Function and Visual Attention Patterns in Patients With Thyroid-Associated Ophthalmopathy

Who this might be right for
Thyroid Associated OphthalmopathiesEye Tracking
Shanghai Changzheng Hospital 100
Not applicableStudy completedNCT03590080
What this trial is testing

Impact of Intravenous Methylprednisolone Treatment on Blood Pressure

Who this might be right for
Graves DiseaseGraves OphthalmopathyHypertension+2 more
Medical University of Warsaw 32
Large-scale testing (Phase 3)Study completedNCT05176639
What this trial is testing

A Safety, Tolerability, and Efficacy Study of Veligrotug (VRDN 001) in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 113
Large-scale testing (Phase 3)Not Yet RecruitingNCT07620405
What this trial is testing

Open-Label Extension Study of MHB018A in Patients With Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease (TED)
Minghui Pharmaceutical (Hangzhou) Ltd 219
Next Page